Cell Isolation Market / Separation Market Size, Share & Trends by Product (Consumables [Media, Kits] Instruments), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose Tissue), Technique (Centrifugation, Filtration), Application (Biomolecule, Cancer) - Global Forecast to 2029
Report Code: BT 2757 Jul, 2024, by marketsandmarkets.com
Cell Isolation Market Size, Share & Trends
The cell isolation market is expected to generate a revenue of USD 8.4 billion by 2029, with a revenue of USD 4.6 billion in 2024 to register a CAGR of 12.9%. The growth of the market can be attributed to the growing focus on technology advancement along with the development of new products that are more economical, technologically advanced, and easy to use. In the past 3 years, key players have launched various cell isolation products such as the next-generation platform of Gibco CTS Detachable Dynabeads (Thermo Fisher Scientific Inc.), BD FACSDiscover S8 cell sorter (BD), CultureOne Maxi (ALFA LAVAL), among others. The launch of these systems is expected to increase their adoption for cell isolation. Furthermore, research activities and funding availability by the government for cell-based research have increased as newer and better treatments for chronic diseases including autoimmune, neurological, and cardiovascular disorders become more necessary. This funding for cell-based research is likely to boost the growth of the market. In addition, various other factors including a surge in cases of cancer and infectious diseases, a growing focus on personalized medicine and next-generation therapeutics are further likely to boost the market growth.
Cell Isolation Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Attractive Opportunities in the Cell Isolation Market
Global Cell Isolation Market Dynamics
DRIVER: Increasing government funding for cell-based research
Cell isolation is mostly used to create new cell therapies and other cell-based treatments. Because of the importance of cell-based research, various government organizations around the world have increased their support for such programs. For example, in June 2024, the National Institute of Neurological Disorders and Stroke awarded the University of Buffalo scientists a five-year grant of approximately USD 2.9 million for a research project aimed at developing a new technology that could improve stem cell therapies for multiple sclerosis (MS) and other neurological diseases.
RESTRAINT: High cost of cell-based research
Cell biology researchers are conducting extensive research to develop new therapies, including gene and stem cell therapies. To obtain accurate results, the instruments, reagents, and other products used in this research must be of high quality, resulting in high cost.
According to a blog published byExcedr 2024, the cost of flow cytometer systems is determined by their component and feature sets. Although some manufacturers, such as Sony Biotechnology Inc (US), are beginning to create flow cytometers for less than USD 100,000, the cost of a single instrument can still range from USD 100,000 to USD 500,000. Furthermore, the cost of conducting cell biology research is significant due to the need to follow regulatory guidelines and maintain high-quality standards. Furthermore, the success rate of cell-based research is extremely restricted, as the majority of cell therapy trials have a low success rate.
OPPORTUNITY: Increasing focus on next-generation therapeutics
Given the widespread success of COVID-19 vaccines, such as mRNA vaccines, the future of protein therapies has gained significant importance. Next-generation protein treatments include tailored antibodies, bi/multi-specific compounds, antibody mimics/novel scaffolds, and ligand/receptor engineers. These novel therapy approaches aim to improve therapeutic efficacy in a variety of diseases by utilizing a wide range of biologics. Promising accurate and successful treatments for diseases such HIV and dementia, antimicrobial medicines include immune-drug combos and immunological mimics such adhirons epitomize the variety in this research. Particularly in complicated diseases with limited therapeutic efficacy, next-generation protein therapeutics show great promise for transforming therapeutic methods with advances in structural biology and recombinant biologics. For example, Evaluate Pharma's (May 2023) statistics show that over 500 ADC medication candidates are now under development. Of these, more than 90% are preclinical in nature.
CHALLENGE: Technical complexities and standardization issues
The market is challenged by technological complexity and standardizing problems, therefore impeding its expansion. The complexity of cell isolation methods including magnetic isolation and flow cytometry demands specialized knowledge and sophisticated equipment, therefore restricting the advanced possibilities of small labs and hospitals. The need for specialized equipment, constant maintenance of such equipment, and the lengthy production time for novel technologies and treatments can all result in increased operational costs. As regulatory requirements are constantly changing and highly variable, standardization efforts are hampered significantly. Furthermore, the lack of standard protocols makes cell separation processes challenging in industrial and therapeutic situations where consistent quality and outcomes are required. As a result, a lack of consistency may result in disparities between research and clinical applications.
Global Cell Isolation Ecosystem Analysis
The cell isolation market ecosystem consists of raw material suppliers, cell isolation product manufacturers, and end users such as pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, and other end users. Cell isolation products manufacturers provide consumables and instruments.
The consumables segment dominated the cell isolation industry in 2023
Based on products, the cell isolation market is segmented into consumables and instruments. The consumables segment is further categories into reagents, kits, media & sera, beads, and disposables. Additionally, beads are categorized into magnetic beads and fluorescent beads. The instrument segment is divided into centrifuges, cell sorters, magnetic-activated cell separator systems, and filtration systems. The consumables segment held the highest position in the market in 2023, due to the high demand for high-quality consumables for biopharmaceutical manufacturing.
The adipose tissue segment dominated the cell isolation industry in 2023
Based on the cell source, the cell isolation market is categorized into adipose tissue, bone marrow, cord blood/embryonic stem cells, and other cell sources. Adipose tissue accounted for the majority of the global market in 2023 due to its widespread use in tissue engineering products. Adipose tissue's potential for cell-based therapies and tissue engineering applications is further influenced by factors such as its ease of access, abundance of therapeutic stem cells, immunomodulatory properties, and regenerative capacity.
North America dominated the cell isolation industry in 2023
The global cell isolation market is divided into six primary regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America led the cell isolation market in 2023, followed by Europe and Asia Pacific. Several reasons contribute to this strong position, such as the well-established healthcare business, substantial investments in research and development activities, and expanded development and production of cell-based drugs.
To know about the assumptions considered for the study, download the pdf brochure
Key players in the cell isolation market include Merck KGaA (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), BD (US), Agilent Technologies, Inc. (US), Miltenyi Biotec (Germany), Revvity (US), Sartorius AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Lonza (Switzerland), QIAGEN (Netherlands), ALFA LAVAL (Sweden), Terumo Corporation (Japan), Corning Incorporated (US), Bio-Rad Laboratories, Inc. (US), GenScript (US), Bio-Techne (US), Takara Bio Inc. (Japan), Standard BioTools (US), Promega Corporation (US), Cell Signaling Technology, Inc. (US), and STEMCELL Technologies (Canada).
Scope of the Cell Isolation Industry:
|
Report Metric |
Details |
|
Market Revenue in 2024 |
$4.6 billion |
|
Projected Revenue by 2029 |
$8.4 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 12.9% |
|
Market Driver |
Increasing government funding for cell-based research |
|
Market Opportunity |
Increasing focus on next-generation therapeutics |
This report categorizes the cell isolation market to forecast revenue and analyze trends in each of the following submarkets:
By Product
-
Consumables
- Reagents, Kits, Media & Sera
-
Beads
- Magnetic Beads
- Fluroscent Beads
- Disposables
-
Instruments
- Centrifuges
- Cell Sorters
- Magnetic-activated Cell Seperator Systems
- Filtration Systems
By Cell Type
-
Human Cells
- Differentiated Cells
- Stem Cells
- Animal Cells
By Cell Source
- Adipose Tissues
- Bone Marrow
- Cord Blood/ Embryonic Stem Cells
- Others
By Technique
- Centrifugation-based Cell Isolation
- Surface-based cell Isolation
- Filtration-based Cell Isolation
By Application
- Biomolecule Isolation
- Cancer Research
- Stem Cell Research
- Tissue Regeneration & Regenerative Medicine
- In-vitro Diagnostics
- Others
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Diagnostic Laboratories
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
-
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific (RoAPAC)
-
Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
-
Middle East
-
GCC Countries
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of GCC Countries (RoGCC)
- Rest of Middle East (RoME)
-
GCC Countries
- Africa
Recent Developments of Cell Isolation Industry:
- In April 2024, Merck KGaA invested over USD 300 million (Euro 300 million) in a new research center at Darmstadt. This advanced research center will focus on developing solutions for antibody manufacturing, mRNA applications, and other biotechnological production needs.
- In September 2023, Thermo Fisher Scientific Inc. launched a next-generation platform of Gibco CTS Detachable Dynabeads, which features an active release mechanism to enable process flexibility, scalability, and cost savings while delivering high cell purity, yield, and viability, accelerating the development and commercialization of cell therapies.
- In March 2023, Danaher Corporation partnered with the University of Pennsylvania to develop technologies for improving the consistency of clinical outcomes for patients and overcoming manufacturing bottlenecks in the delivery of next-generation engineered cell therapies.
Frequently Asked Questions (FAQ):
Who are the key players in the cell isolation market?
Key players in the cell isolation market include Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), and BD (US).
Which product segment dominates the cell isolation market?
Consumables segment dominated the cell isolation market, due to increasing focus on development of advanced biotherapeutics products. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 41)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 SEGMENTS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.3.4.1 Value unit
1.3.4.2 Volume unit
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 47)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS
2.8 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 61)
4 PREMIUM INSIGHTS (Page No. - 67)
4.1 CELL ISOLATION MARKET OVERVIEW
4.2 NORTH AMERICAN CELL ISOLATION INDUSTRY, BY TYPE AND COUNTRY
4.3 MARKET SHARE, BY APPLICATION
4.4 MARKET SHARE, BY END USER
4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW (Page No. - 71)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing government funding for cell-based research
5.2.1.2 Surge in cases of cancer and infectious diseases
5.2.1.3 Rising emphasis on technological advancements and product developments
5.2.1.4 Growing focus on personalized medicine
5.2.2 RESTRAINTS
5.2.2.1 Ethical and safety issues
5.2.2.2 High cost of cell-based research
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.3.2 Increasing focus on next-generation therapeutics
5.2.4 CHALLENGES
5.2.4.1 Complex development process of cell therapies
5.2.4.2 Technical complexities and stringent regulatory requirements
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Centrifugation-based techniques
5.4.1.2 Magnetic cell isolation
5.4.1.3 Fluorescence-activated cell sorting
5.4.1.4 Acoustic cell isolation
5.4.1.5 Acoustofluidic cell isolation
5.4.1.6 Microfiltration
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Mass cytometry
5.4.2.2 Cell imaging technologies
5.4.2.3 Artificial intelligence and machine learning
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Single-cell sequencing
5.4.3.2 Clustered regularly interspaced short palindromic repeats and gene editing
5.4.3.3 3D cell culture
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.5.2 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TECHNIQUE
5.5.3 AVERAGE SELLING PRICE TREND, BY REGION
5.6 VALUE CHAIN ANALYSIS
5.7 PATENT ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
5.9.1 ROLE OF RAW MATERIAL VENDORS
5.9.2 ROLE OF PRODUCT PROVIDERS
5.9.3 ROLE OF END USERS
5.9.4 ROLE OF REGULATORY AUTHORITIES
5.10 REGULATORY LANDSCAPE
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.2 REGULATORY SCENARIO
5.11 PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF SUPPLIERS
5.11.4 BARGAINING POWER OF BUYERS
5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 KEY CONFERENCES AND EVENTS, 2024–2025
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 TRADE ANALYSIS
5.14.1 IMPORT DATA FOR HS CODE 382200
5.14.2 EXPORT DATA FOR HS CODE 382200
5.15 INVESTMENT AND FUNDING SCENARIO
5.16 IMPACT OF GENERATIVE AI ON MARKET
6 CELL ISOLATION MARKET, BY PRODUCT (Page No. - 109)
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 REAGENTS, KITS, MEDIA, AND SERA
6.2.1.1 Surge in product launches and repetitive purchases to boost segment growth
6.2.2 BEADS
6.2.2.1 Magnetic beads
6.2.2.1.1 Growing demand in biomedical research and clinical applications to drive market
6.2.2.2 Fluorescent beads
6.2.2.2.1 Increasing use in flow cytometry, cell sorting, and imaging applications to fuel market
6.2.3 DISPOSABLES
6.2.3.1 Growing government investments in research to aid market growth
6.3 INSTRUMENTS
6.3.1 CENTRIFUGES
6.3.1.1 Growing use in pharma-biotech industry to boost market
6.3.2 CELL SORTERS
6.3.2.1 Rise in cell-based research initiatives to augment growth
6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
6.3.3.1 Booming use in research for T-cell and stem cell isolation to drive market
6.3.4 FILTRATION SYSTEMS
6.3.4.1 Rising need to ensure Good Manufacturing Practice standards and regulations to boost market
7 CELL ISOLATION MARKET, BY CELL TYPE (Page No. - 151)
7.1 INTRODUCTION
7.2 HUMAN CELLS
7.2.1 DIFFERENTIATED CELLS
7.2.1.1 Increasing use in disease modeling, regenerative medicine, and gene therapy to fuel growth
7.2.2 STEM CELLS
7.2.2.1 Rise in grants and funding for stem cell research to drive market
7.3 ANIMAL CELLS
7.3.1 GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH
8 CELL ISOLATION MARKET, BY CELL SOURCE (Page No. - 167)
8.1 INTRODUCTION
8.2 ADIPOSE TISSUE
8.2.1 INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET
8.3 BONE MARROW
8.3.1 GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH
8.4 CORD BLOOD/EMBRYONIC STEM CELLS
8.4.1 HIGH THERAPEUTIC POTENCY TO SUPPORT MARKET GROWTH
8.5 OTHER CELL SOURCES
9 CELL ISOLATION MARKET, BY TECHNIQUE (Page No. - 182)
9.1 INTRODUCTION
9.2 CENTRIFUGATION-BASED CELL ISOLATION
9.2.1 RISE IN USE BY BIOTECH AND BIOPHARMACEUTICAL COMPANIES TO FUEL MARKET
9.3 SURFACE MARKER-BASED CELL ISOLATION
9.3.1 INCREASING ADOPTION OF MAGNETIC-ACTIVATED CELL SORTING TO PROPEL MARKET
9.4 FILTRATION-BASED CELL ISOLATION
9.4.1 NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET
10 CELL ISOLATION MARKET, BY APPLICATION (Page No. - 195)
10.1 INTRODUCTION
10.2 BIOMOLECULE ISOLATION
10.2.1 INCREASING DEMAND FOR BIOPHARMACEUTICAL PRODUCTS TO FUEL MARKET
10.3 CANCER RESEARCH
10.3.1 GROWING INCLINATION TOWARD DEVELOPING AND MANUFACTURING CANCER TREATMENTS TO DRIVE MARKET
10.4 STEM CELL RESEARCH
10.4.1 RISING GRANTS AND FUNDING FOR STEM CELL RESEARCH TO AUGMENT GROWTH
10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE
10.5.1 GROWING INITIATIVES FOR RESEARCH IN REGENERATIVE MEDICINE TO SUPPORT MARKET
10.6 IN VITRO DIAGNOSTICS
10.6.1 NEED FOR ACCURACY TO IDENTIFY CELL TYPE TO PROPEL MARKET
10.7 OTHER APPLICATIONS
11 CELL ISOLATION MARKET, BY END USER (Page No. - 218)
11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.2.1 INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH
11.3 ACADEMIC & RESEARCH INSTITUTES
11.3.1 HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT
11.4 HOSPITALS & DIAGNOSTIC LABORATORIES
11.4.1 INCREASING NUMBER OF HEALTHCARE FACILITIES IN EMERGING ECONOMIES TO DRIVE MARKET
11.5 OTHER END USERS
12 CELL ISOLATION MARKET, BY REGION (Page No. - 234)
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 NORTH AMERICA: RECESSION IMPACT
12.2.2 US
12.2.2.1 Rising prevalence of cancer to drive market
12.2.3 CANADA
12.2.3.1 Increased government funding for stem cell and vaccine research to propel market
12.3 EUROPE
12.3.1 EUROPE: RECESSION IMPACT
12.3.2 GERMANY
12.3.2.1 Rising interest in biotechnology drugs and applications to aid market growth
12.3.3 UK
12.3.3.1 Increasing prevalence of infectious diseases to drive market
12.3.4 FRANCE
12.3.4.1 Surge in investments in cell biology research activities to drive market
12.3.5 ITALY
12.3.5.1 Rising number of cell biology seminars and conferences to drive market
12.3.6 SPAIN
12.3.6.1 Increasing funding from private and public organizations to aid growth
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 ASIA PACIFIC: RECESSION IMPACT
12.4.2 CHINA
12.4.2.1 Increasing investments in research and technological advancements to boost market
12.4.3 JAPAN
12.4.3.1 Dominant geriatric population to aid market growth
12.4.4 INDIA
12.4.4.1 Growing penetration of healthcare insurance services to propel market
12.4.5 AUSTRALIA
12.4.5.1 Growing emphasis on personalized medicine, biopharmaceuticals, and advanced therapies to fuel market
12.4.6 SOUTH KOREA
12.4.6.1 Rising need for therapeutics to support market growth
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 LATIN AMERICA: RECESSION IMPACT
12.5.2 BRAZIL
12.5.2.1 Need to improve public access to modern healthcare facilities to drive market
12.5.3 MEXICO
12.5.3.1 Favorable trade agreements to support market
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 MIDDLE EAST: RECESSION IMPACT
12.6.2 GCC
12.6.2.1 Saudi Arabia
12.6.2.1.1 Growing focus on Vision 2030 initiatives to boost market
12.6.2.2 UAE
12.6.2.2.1 Rising inclination toward producing high-value specialty drugs to aid market growth
12.6.2.3 Rest of GCC Countries
12.6.3 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 INCREASING PATIENT POPULATION WITH CANCER TO PROPEL MARKET
12.7.2 AFRICA: RECESSION IMPACT
13 COMPETITIVE LANDSCAPE (Page No. - 360)
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION INDUSTRY
13.3 REVENUE ANALYSIS, 2021–2023
13.4 MARKET SHARE ANALYSIS, 2023
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Type footprint
13.5.5.4 Cell type footprint
13.5.5.5 End user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES (Page No. - 383)
14.1 KEY PLAYERS
14.1.1 DANAHER CORPORATION
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses and competitive threats
14.1.2 MERCK KGAA
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Deals
14.1.2.3.2 Expansions
14.1.2.4 MnM view
14.1.2.4.1 Key strengths
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses and competitive threats
14.1.3 THERMO FISHER SCIENTIFIC INC.
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 BD
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches
14.1.4.3.2 Deals
14.1.4.3.3 Other developments
14.1.5 SARTORIUS AG
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Deals
14.1.6 AGILENT TECHNOLOGIES, INC.
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.7 BIO-RAD LABORATORIES, INC.
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.8 QIAGEN
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Deals
14.1.9 F. HOFFMANN-LA ROCHE LTD.
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 REVVITY
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Other developments
14.1.11 CORNING INCORPORATED
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 LONZA
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches
14.1.12.3.2 Deals
14.1.13 BIO-TECHNE
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.3 Recent developments
14.1.13.3.1 Deals
14.1.13.3.2 Other developments
14.1.14 TERUMO CORPORATION
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.14.3 Recent developments
14.1.14.3.1 Deals
14.1.15 MILTENYI BIOTEC
14.1.15.1 Business overview
14.1.15.2 Products offered
14.1.16 TAKARA BIO INC.
14.1.16.1 Business overview
14.1.16.2 Products offered
14.1.16.3 Recent developments
14.1.16.3.1 Deals
14.1.17 GENSCRIPT
14.1.17.1 Business overview
14.1.17.2 Products offered
14.1.17.3 Recent developments
14.1.17.3.1 Deals
14.1.18 STANDARD BIOTOOLS
14.1.18.1 Business overview
14.1.18.2 Products offered
14.1.19 ALFA LAVAL
14.1.19.1 Business overview
14.1.19.2 Products offered
14.1.19.3 Recent developments
14.1.19.3.1 Product launches
14.1.19.3.2 Deals
14.2 OTHER PLAYERS
14.2.1 PROMEGA CORPORATION
14.2.2 CELL SIGNALING TECHNOLOGY, INC.
14.2.3 MICAREO INC.
14.2.4 APPLIED CELLS INC.
14.2.5 STEMCELL TECHNOLOGIES
14.2.6 CREATIVE BIOARRAY
14.2.7 PROTEINTECH GROUP, INC.
14.2.8 MAGBIO GENOMICS, INC.
14.2.9 AKADEUM LIFE SCIENCES
14.2.10 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG
14.2.11 INVENT BIOTECHNOLOGIES, INC.
15 APPENDIX (Page No. - 466)
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
LIST OF TABLES (631 TABLES)
TABLE 1 CELL ISOLATION MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 3 IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 4 NATIONAL INSTITUTES OF HEALTH FUNDING FOR CELL-BASED RESEARCH, 2019–2025 (USD MILLION)
TABLE 5 CANCER INCIDENCE WORLDWIDE, 2020 VS. 2040
TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015–2022
TABLE 7 INVESTMENT ROUNDS IN ASIA PACIFIC BIOTECH COMPANIES, 2023
TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2023 (USD)
TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 (USD)
TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024
TABLE 11 CELL ISOLATION INDUSTRY: ROLE OF RAW MATERIAL VENDORS IN ECOSYSTEM
TABLE 12 CELL ISOLATION INDUSTRY: ROLE OF PRODUCT PROVIDERS IN ECOSYSTEM
TABLE 13 CELL ISOLATION INDUSTRY: ROLE OF END USERS IN ECOSYSTEM
TABLE 14 CELL ISOLATION INDUSTRY: ROLE OF REGULATORY AUTHORITIES IN ECOSYSTEM
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REGULATORY GUIDELINES
TABLE 20 IMPACT OF PORTER’S FIVE FORCES
TABLE 21 KEY CONFERENCES AND EVENTS, 2024–2025
TABLE 22 BUYING CRITERIA, BY END USER
TABLE 23 IMPORT VALUE FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019–2023 (USD THOUSAND)
TABLE 24 IMPORT VOLUME FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019–2023 (TONS)
TABLE 25 EXPORT VALUE FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019–2023 (USD THOUSAND)
TABLE 26 EXPORT VOLUME FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019–2023 (TONS)
TABLE 27 CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 28 MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 29 NORTH AMERICA: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 EUROPE: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 ASIA PACIFIC: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 LATIN AMERICA: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 33 MIDDLE EAST: MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 GCC COUNTRIES: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 36 MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2022–2029 (USD MILLION)
TABLE 37 NORTH AMERICA: MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 EUROPE: MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 ASIA PACIFIC: MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 LATIN AMERICA: MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 MIDDLE EAST: MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2022–2029 (USD MILLION)
TABLE 42 GCC COUNTRIES: MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 MARKET FOR BEADS, BY REGION, 2022–2029 (USD MILLION)
TABLE 44 NORTH AMERICA: MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 EUROPE: MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 ASIA PACIFIC: MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 LATIN AMERICA: MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 MIDDLE EAST: MARKET FOR BEADS, BY REGION, 2022–2029 (USD MILLION)
TABLE 49 GCC COUNTRIES: MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 51 CELL ISOLATION INDUSTRY FOR MAGNETIC BEADS, BY REGION, 2022–2029 (USD MILLION)
TABLE 52 NORTH AMERICA: MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 EUROPE: MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 ASIA PACIFIC: MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 LATIN AMERICA: MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 MIDDLE EAST: MARKET FOR MAGNETIC BEADS, BY REGION, 2022–2029 (USD MILLION)
TABLE 57 GCC COUNTRIES: MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 MARKET FOR FLUORESCENT BEADS, BY REGION, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 EUROPE: MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 ASIA PACIFIC: MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 LATIN AMERICA: MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 MIDDLE EAST: MARKET FOR FLUORESCENT BEADS, BY REGION, 2022–2029 (USD MILLION)
TABLE 64 GCC COUNTRIES: MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 MARKET FOR DISPOSABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 66 NORTH AMERICA: MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 EUROPE: MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 ASIA PACIFIC: MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 LATIN AMERICA: MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 MIDDLE EAST: MARKET FOR DISPOSABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 71 GCC COUNTRIES: MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 EUROPE: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 LATIN AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 MIDDLE EAST: MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 78 GCC COUNTRIES: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 80 CELL ISOLATION INDUSTRY FOR CENTRIFUGES, BY REGION, 2022–2029 (USD MILLION)
TABLE 81 NORTH AMERICA: MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 EUROPE: MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 ASIA PACIFIC: MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 LATIN AMERICA: MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 MIDDLE EAST: MARKET FOR CENTRIFUGES, BY REGION, 2022–2029 (USD MILLION)
TABLE 86 GCC COUNTRIES MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 MARKET FOR CELL SORTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 EUROPE: MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 ASIA PACIFIC: MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 LATIN AMERICA: MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 MIDDLE EAST: MARKET FOR CELL SORTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 93 GCC COUNTRIES: MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 EUROPE: MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 ASIA PACIFIC: MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 LATIN AMERICA: MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 MIDDLE EAST: MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 100 GCC COUNTRIES: MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 MARKET FOR FILTRATION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 102 NORTH AMERICA: MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 EUROPE: MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 ASIA PACIFIC: MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 LATIN AMERICA: MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 MIDDLE EAST: MARKET FOR FILTRATION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 107 GCC COUNTRIES: MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 109 CELL ISOLATION INDUSTRY FOR HUMAN CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 110 NORTH AMERICA: MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 EUROPE: MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 LATIN AMERICA: MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 MIDDLE EAST: MARKET FOR HUMAN CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 115 GCC COUNTRIES: MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 117 MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 118 NORTH AMERICA: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 EUROPE: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 LATIN AMERICA: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 MIDDLE EAST: MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 123 GCC COUNTRIES: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 125 NORTH AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 EUROPE: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 ASIA PACIFIC: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 LATIN AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 MIDDLE EAST: MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 130 GCC COUNTRIES: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 MARKET FOR ANIMAL CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 132 NORTH AMERICA: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 EUROPE: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 LATIN AMERICA: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 MIDDLE EAST: MARKET FOR ANIMAL CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 137 GCC COUNTRIES: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 139 CELL ISOLATION INDUSTRY FOR ADIPOSE TISSUE, BY REGION, 2022–2029 (USD MILLION)
TABLE 140 NORTH AMERICA: MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 EUROPE: MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 ASIA PACIFIC: MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 LATIN AMERICA: MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 MIDDLE EAST: MARKET FOR ADIPOSE TISSUE, BY REGION, 2022–2029 (USD MILLION)
TABLE 145 GCC COUNTRIES: MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 MARKET FOR BONE MARROW, BY REGION, 2022–2029 (USD MILLION)
TABLE 147 NORTH AMERICA: MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 EUROPE: MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 149 ASIA PACIFIC: MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 LATIN AMERICA: MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 MIDDLE EAST: MARKET FOR BONE MARROW, BY REGION, 2022–2029 (USD MILLION)
TABLE 152 GCC COUNTRIES: MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 154 NORTH AMERICA: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 EUROPE: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 156 ASIA PACIFIC: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 157 LATIN AMERICA: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 MIDDLE EAST: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 159 GCC COUNTRIES: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 MARKET FOR OTHER CELL SOURCES, BY REGION, 2022–2029 (USD MILLION)
TABLE 161 NORTH AMERICA: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 EUROPE: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163 ASIA PACIFIC: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164 LATIN AMERICA: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 MIDDLE EAST: MARKET FOR OTHER CELL SOURCES, BY REGION, 2022–2029 (USD MILLION)
TABLE 166 GCC COUNTRIES: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 168 CELL ISOLATION INDUSTRY FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 169 NORTH AMERICA: MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 EUROPE: MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 ASIA PACIFIC: MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 172 LATIN AMERICA: MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 MIDDLE EAST: MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 174 GCC COUNTRIES: MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 175 MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 176 NORTH AMERICA: MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 177 EUROPE: MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 ASIA PACIFIC: MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 LATIN AMERICA: MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 MIDDLE EAST: MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 181 GCC COUNTRIES: MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 MARKET FOR FILTRATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 183 NORTH AMERICA: MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 EUROPE: MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 LATIN AMERICA: MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 MIDDLE EAST: MARKET FOR FILTRATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 188 GCC COUNTRIES: MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 190 CELL ISOLATION INDUSTRY FOR BIOMOLECULE ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 191 NORTH AMERICA: MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 EUROPE: MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 193 ASIA PACIFIC: MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 LATIN AMERICA: MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 MIDDLE EAST: MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 196 GCC COUNTRIES: MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 MARKET FOR CANCER RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 198 NORTH AMERICA: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 EUROPE: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 200 ASIA PACIFIC: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 LATIN AMERICA: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 MIDDLE EAST: MARKET FOR CANCER RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 203 GCC COUNTRIES: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 205 NORTH AMERICA: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 206 EUROPE: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 207 ASIA PACIFIC: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 LATIN AMERICA: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 MIDDLE EAST: MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 210 GCC COUNTRIES: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
TABLE 212 NORTH AMERICA: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 213 EUROPE: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 214 ASIA PACIFIC: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 215 LATIN AMERICA: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 MIDDLE EAST: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
TABLE 217 GCC COUNTRIES: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 219 NORTH AMERICA: MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 220 EUROPE: MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 221 ASIA PACIFIC: MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 222 LATIN AMERICA: MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 MIDDLE EAST: MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 224 GCC COUNTRIES: MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 CELL ISOLATION INDUSTRY FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 226 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 227 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 229 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 MIDDLE EAST: MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 231 GCC COUNTRIES: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 233 CELL ISOLATION INDUSTRY FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 234 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 236 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 MIDDLE EAST: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 239 GCC COUNTRIES: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 241 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 244 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245 MIDDLE EAST: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 246 GCC COUNTRIES: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 248 NORTH AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 EUROPE: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 250 ASIA PACIFIC: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 251 LATIN AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252 MIDDLE EAST: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 253 GCC COUNTRIES: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 255 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 257 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 258 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259 MIDDLE EAST: MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 260 GCC COUNTRIES: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 CELL ISOLATION MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 262 NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 NORTH AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 264 NORTH AMERICA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 265 NORTH AMERICA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 266 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 267 NORTH AMERICA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 268 NORTH AMERICA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 NORTH AMERICA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 270 NORTH AMERICA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 271 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 272 NORTH AMERICA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 273 US: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 274 US: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 275 US: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 276 US: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 277 US: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 278 US: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 279 US: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 280 US: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 281 US: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 282 US: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 283 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 284 CANADA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 285 CANADA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 286 CANADA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 287 CANADA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 288 CANADA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 289 CANADA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 290 CANADA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 291 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 292 CANADA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 293 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 294 EUROPE: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 295 EUROPE: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 296 EUROPE: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 297 EUROPE: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 298 EUROPE: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 299 EUROPE: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 300 EUROPE: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 301 EUROPE: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 302 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 303 EUROPE: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 304 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 305 GERMANY: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 306 GERMANY: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 307 GERMANY: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 308 GERMANY: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 309 GERMANY: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 310 GERMANY: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 311 GERMANY: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 312 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 313 GERMANY: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 314 UK: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 315 UK: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 316 UK: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 317 UK: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 318 UK: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 319 UK: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 320 UK: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 321 UK: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 322 UK: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 323 UK: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 324 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 325 FRANCE: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 326 FRANCE: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 327 FRANCE: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 328 FRANCE: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 329 FRANCE: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 330 FRANCE: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 331 FRANCE: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 332 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 333 FRANCE: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 334 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 335 ITALY: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 336 ITALY: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 ITALY: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 338 ITALY: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 339 ITALY: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 ITALY: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 341 ITALY: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 342 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 343 ITALY: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 344 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 345 SPAIN: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 346 SPAIN: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 347 SPAIN: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 348 SPAIN: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 349 SPAIN: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 SPAIN: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 351 SPAIN: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 352 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 353 SPAIN: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 354 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 355 REST OF EUROPE: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 356 REST OF EUROPE: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 357 REST OF EUROPE: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 358 REST OF EUROPE: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 359 REST OF EUROPE: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 REST OF EUROPE: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 361 REST OF EUROPE: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 362 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 363 REST OF EUROPE: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 364 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 365 ASIA PACIFIC: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 366 ASIA PACIFIC: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 367 ASIA PACIFIC: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 368 ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 369 ASIA PACIFIC: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 370 ASIA PACIFIC: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 371 ASIA PACIFIC: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 372 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 373 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 374 ASIA PACIFIC: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 375 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 376 CHINA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 CHINA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 CHINA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 379 CHINA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 380 CHINA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 381 CHINA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 382 CHINA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 383 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 384 CHINA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 385 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 386 JAPAN: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 JAPAN: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 388 JAPAN: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 389 JAPAN: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 390 JAPAN: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 391 JAPAN: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 392 JAPAN: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 393 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 394 JAPAN: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 395 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 396 INDIA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 397 INDIA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 INDIA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 399 INDIA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 400 INDIA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 INDIA: MARKET, BY CELL SOURCE, .2022–2029 (USD MILLION)
TABLE 402 INDIA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 403 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 404 INDIA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 405 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 406 AUSTRALIA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 407 AUSTRALIA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 408 AUSTRALIA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 409 AUSTRALIA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 410 AUSTRALIA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 AUSTRALIA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 412 AUSTRALIA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 413 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 414 AUSTRALIA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 415 SOUTH KOREA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 416 SOUTH KOREA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 417 SOUTH KOREA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 418 SOUTH KOREA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 419 SOUTH KOREA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 420 SOUTH KOREA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 421 SOUTH KOREA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 422 SOUTH KOREA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 423 SOUTH KOREA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 424 SOUTH KOREA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 425 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 426 REST OF ASIA PACIFIC: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 REST OF ASIA PACIFIC: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 428 REST OF ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 429 REST OF ASIA PACIFIC: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 430 REST OF ASIA PACIFIC: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 431 REST OF ASIA PACIFIC: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 432 REST OF ASIA PACIFIC: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 433 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 434 REST OF ASIA PACIFIC: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 435 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 436 LATIN AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 437 LATIN AMERICA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 438 LATIN AMERICA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 439 LATIN AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 440 LATIN AMERICA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 441 LATIN AMERICA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 442 LATIN AMERICA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 443 LATIN AMERICA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 444 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 445 LATIN AMERICA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 446 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 447 BRAZIL: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 448 BRAZIL: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 449 BRAZIL: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 450 BRAZIL: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 451 BRAZIL: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 452 BRAZIL: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 453 BRAZIL: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 454 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 455 BRAZIL: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 456 MEXICO: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 457 MEXICO: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 458 MEXICO: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 459 MEXICO: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 460 MEXICO: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 461 MEXICO: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 462 MEXICO: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 463 MEXICO: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 464 MEXICO: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 465 MEXICO: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 466 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 467 REST OF LATIN AMERICA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 468 REST OF LATIN AMERICA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 469 REST OF LATIN AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 470 REST OF LATIN AMERICA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 471 REST OF LATIN AMERICA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 472 REST OF LATIN AMERICA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 473 REST OF LATIN AMERICA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 474 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 475 REST OF LATIN AMERICA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 476 MIDDLE EAST: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 477 MIDDLE EAST: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 478 MIDDLE EAST: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 479 MIDDLE EAST: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 480 MIDDLE EAST: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 481 MIDDLE EAST: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 482 MIDDLE EAST: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 483 MIDDLE EAST: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 484 MIDDLE EAST: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 485 MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 486 MIDDLE EAST: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 487 GCC: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 488 GCC: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 489 GCC: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 490 GCC: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 491 GCC: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 492 GCC: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 493 GCC: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 494 GCC: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 495 GCC: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 496 GCC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 497 GCC: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 498 SAUDI ARABIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 499 SAUDI ARABIA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 500 SAUDI ARABIA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 501 SAUDI ARABIA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 502 SAUDI ARABIA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 503 SAUDI ARABIA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 504 SAUDI ARABIA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 505 SAUDI ARABIA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 506 SAUDI ARABIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 507 SAUDI ARABIA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 508 UAE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 509 UAE: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 510 UAE: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 511 UAE: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 512 UAE: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 513 UAE: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 514 UAE: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 515 UAE: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 516 UAE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 517 UAE: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 518 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 519 REST OF GCC COUNTRIES: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 520 REST OF GCC COUNTRIES: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 521 REST OF GCC COUNTRIES: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 522 REST OF GCC COUNTRIES: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 523 REST OF GCC COUNTRIES: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 524 REST OF GCC COUNTRIES: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 525 REST OF GCC COUNTRIES: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 526 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 527 REST OF GCC COUNTRIES: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 528 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 529 REST OF MIDDLE EAST: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 530 REST OF MIDDLE EAST: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 531 REST OF MIDDLE EAST: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 532 REST OF MIDDLE EAST: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 533 REST OF MIDDLE EAST: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 534 REST OF MIDDLE EAST: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 535 REST OF MIDDLE EAST: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 536 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 537 REST OF MIDDLE EAST: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 538 AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 539 AFRICA: MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 540 AFRICA: MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 541 AFRICA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 542 AFRICA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 543 AFRICA: MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 544 AFRICA: MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 545 AFRICA: MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 546 AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 547 AFRICA: CELL ISOLATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
TABLE 548 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 549 MARKET: DEGREE OF COMPETITION
TABLE 550 MARKET: REGION FOOTPRINT
TABLE 551 MARKET: PRODUCT FOOTPRINT
TABLE 552 MARKET: CELL TYPE FOOTPRINT
TABLE 553 MARKET: END USER FOOTPRINT
TABLE 554 MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 555 MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 556 MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 557 MARKET: DEALS, JANUARY 2021–JUNE 2024
TABLE 558 MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 559 MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 560 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 561 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 562 DANAHER CORPORATION: DEALS, JANUARY 2021–JUNE 2024
TABLE 563 MERCK KGAA: COMPANY OVERVIEW
TABLE 564 MERCK KGAA: PRODUCTS OFFERED
TABLE 565 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2024
TABLE 566 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 567 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 568 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 569 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 570 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 571 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 572 BD: COMPANY OVERVIEW
TABLE 573 BD: PRODUCTS OFFERED
TABLE 574 BD: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 575 BD: DEALS, JANUARY 2021–JUNE 2024
TABLE 576 BD: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 577 SARTORIUS AG: COMPANY OVERVIEW
TABLE 578 SARTORIUS AG: PRODUCTS OFFERED
TABLE 579 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2024
TABLE 580 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 581 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 582 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 583 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 584 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 585 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 586 QIAGEN: COMPANY OVERVIEW
TABLE 587 QIAGEN: PRODUCTS OFFERED
TABLE 588 QIAGEN: DEALS, JANUARY 2021–JUNE 2024
TABLE 589 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 590 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 591 REVVITY: COMPANY OVERVIEW
TABLE 592 REVVITY: PRODUCTS OFFERED
TABLE 593 REVVITY: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 594 CORNING INCORPORATED: COMPANY OVERVIEW
TABLE 595 CORNING INCORPORATED: PRODUCTS OFFERED
TABLE 596 LONZA: COMPANY OVERVIEW
TABLE 597 LONZA: PRODUCTS OFFERED
TABLE 598 LONZA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 599 LONZA: DEALS, JANUARY 2021–JUNE 2024
TABLE 600 BIO-TECHNE: COMPANY OVERVIEW
TABLE 601 BIO-TECHNE: PRODUCTS OFFERED
TABLE 602 BIO-TECHNE: DEALS, JANUARY 2021–JUNE 2024
TABLE 603 BIO-TECHNE: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 604 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 605 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 606 TERUMO CORPORATION: DEALS, JANUARY 2021–JUNE 2024
TABLE 607 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 608 MILTENYI BIOTEC: PRODUCTS OFFERED
TABLE 609 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 610 TAKARA BIO INC.: PRODUCTS OFFERED
TABLE 611 TAKARA BIO INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 612 GENSCRIPT: COMPANY OVERVIEW
TABLE 613 GENSCRIPT: PRODUCTS OFFERED
TABLE 614 GENSCRIPT: DEALS, JANUARY 2021–JUNE 2024
TABLE 615 STANDARD BIOTOOLS: COMPANY OVERVIEW
TABLE 616 STANDARD BIOTOOLS: PRODUCTS OFFERED
TABLE 617 ALFA LAVAL: COMPANY OVERVIEW
TABLE 618 ALFA LAVAL: PRODUCTS OFFERED
TABLE 619 ALFA LAVAL: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 620 ALFA LAVAL: DEALS, JANUARY 2021–JUNE 2024
TABLE 621 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 622 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 623 MICAREO INC.: COMPANY OVERVIEW
TABLE 624 APPLIED CELLS INC.: COMPANY OVERVIEW
TABLE 625 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
TABLE 626 CREATIVE BIOARRAY: COMPANY OVERVIEW
TABLE 627 PROTEINTECH GROUP, INC.: COMPANY OVERVIEW
TABLE 628 MAGBIO GENOMICS, INC.: COMPANY OVERVIEW
TABLE 629 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW
TABLE 630 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG: COMPANY OVERVIEW
TABLE 631 INVENT BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
LIST OF FIGURES (62 FIGURES)
FIGURE 1 CELL ISOLATION MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 4 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2023
FIGURE 7 INSIGHTS FROM PRIMARY SOURCES
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 9 MARKET: CAGR PROJECTIONS
FIGURE 10 DATA TRIANGULATION
FIGURE 11 MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 12 MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 MARKET, BY CELL SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
FIGURE 15 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 16 MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF MARKET
FIGURE 18 INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH AND GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET
FIGURE 19 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
FIGURE 20 BIOMOLECULE ISOLATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 21 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED MARKET IN 2023
FIGURE 22 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 23 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 24 GLOBAL HIV EPIDEMIC, 2022
FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS
FIGURE 26 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TECHNIQUE, 2021–2023 (USD)
FIGURE 27 VALUE CHAIN ANALYSIS
FIGURE 28 PATENT ANALYSIS, 2014–2024
FIGURE 29 SUPPLY CHAIN ANALYSIS
FIGURE 30 ECOSYSTEM ANALYSIS
FIGURE 31 PORTER’S FIVE FORCES
FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
FIGURE 33 BUYING CRITERIA, BY END USER
FIGURE 34 FLUORESCENCE-ACTIVATED CELL SORTERS MARKET, 2022–2029 (UNITS)
FIGURE 35 NORTH AMERICA: MARKET SNAPSHOT
FIGURE 36 ASIA PACIFIC: MARKET SNAPSHOT
FIGURE 37 REVENUE ANALYSIS OF TOP 4 PLAYERS, 2021–2023 (USD MILLION)
FIGURE 38 MARKET SHARE ANALYSIS, 2023
FIGURE 39 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 40 MARKET: COMPANY FOOTPRINT
FIGURE 41 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 42 COMPANY VALUATION
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 44 MARKET: BRAND/PRODUCT COMPARISON
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 48 BD: COMPANY SNAPSHOT (2023)
FIGURE 49 SARTORIUS AG: COMPANY SNAPSHOT (2023)
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2023)
FIGURE 53 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
FIGURE 54 REVVITY: COMPANY SNAPSHOT (2023)
FIGURE 55 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
FIGURE 56 LONZA: COMPANY SNAPSHOT (2023)
FIGURE 57 BIO-TECHNE: COMPANY SNAPSHOT (2023)
FIGURE 58 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 59 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
FIGURE 60 GENSCRIPT: COMPANY SNAPSHOT (2023)
FIGURE 61 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023)
FIGURE 62 ALFA LAVAL: COMPANY SNAPSHOT (2023)
This research study includes significant use of secondary sources, directories, and databases to discover and collect valuable information for analyzing the global cell isolation market. In-depth interviews were conducted with a variety of primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to gather and verify critical qualitative and quantitative data and assess the market's growth prospects. The global market size determined from secondary research was then triangulated with primary research inputs to calculate the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell isolation market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), Stem Cell Society Singapore (SCSS), International Society for Advancement of Cytometry (ISAC), and American Filtration and Separations Society (AFS), Food and Drug Administration (FDA), American Society for Cell Biology (ASCB), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT), American Society for Gene and Cell Therapy (ASGCT), Pharmaceutical Research and Manufacturers of America (PhRMA), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), and the Alliance for Regenerative Medicine (ARM), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global cell isolation market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, CROs, and CMOs, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were done in five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. About 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This data was gathered using questionnaires, e-mails, online surveys, in-person interviews, and telephone interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell isolation market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Bottom-up Approach
- The key players in the industry and market have been identified through extensive secondary research
- The revenues generated from the cell isolation business of leading players have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Cell isolation/cell separation is the process used for separation of an individual cell type from heterogeneous cell populations without contamination from another cell type. Cell isolation instruments and consuambles are widely used for various application from biological research to production of vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.
Stakeholders
- Cell Isolation Product Manufacturers
- Cell Biology Associations
- Research & Consulting Firms
- Distributors of Cell Isolation Products
- Contract Manufacturers of Global Cell Isolation Products
- Biotechnology, Biopharmaceutical, and Pharmaceutical Companies
- Healthcare Institutes (Hospitals, Medical Schools, Diagnostic Centers, Cell Banks, and Outpatient Clinics)
- Research Institutes and Clinical Research Organizations (CROs)
- Venture Capitalists
- Insurance Providers
- Government Bodies
Report Objectives
- To define, describe, and forecast the global cell isolation market by product, cell type, cell source, technique, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to their individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the revenue of the market segments with respect to six major regions:
- North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches, agreements, partnerships, collaborations, acquisitions, and expansions in the cell isolation market
- To benchmark players within the cell isolation market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe cell isolation market into countries
- A further breakdown of the Rest of Asia Pacific cell isolation market into countries
- A further breakdown of the Rest of Latin American cell isolation market into countries
- A further breakdown of the Rest of Middle East cell isolation market into countries
Generating Response ...
Growth opportunities and latent adjacency in Cell Isolation Market